Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Shiver

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical Sciences|December 1, 1996
Humoral and cellular immunities elicited by HIV-1 vaccinationJ W Shiver, M E Davies, H C Perry, et al.
Methods in Enzymology|January 1, 1989
Prediction of bilayer spanning domains of hydrophobic and amphipathic membrane proteins: application to the cytochrome b and colicin familiesJ W Shiver, A A Peterson, W R Widger, et al.
Current Opinion in Biotechnology|October 1, 1994
Protein expression in vivo by injection of polynucleotidesD L Montgomery, J J Donnelly, J W Shiver, et al.
The Journal of Biological Chemistry|October 15, 1987
On the explanation of the acidic pH requirement for in vitro activity of colicin E1. Site-directed mutagenesis at Glu-468J W Shiver, W A Cramer, F S Cohen, et al.
Immunology Letters|October 12, 2001
Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeysD H Barouch, T M Fu, D C Montefiori, et al.
The Journal of Biological Chemistry|February 5, 1989
Decrease of anion selectivity caused by mutation of Thr501 and Gly502 to Glu in the hydrophobic domain of the colicin E1 channelK Shirabe, F S Cohen, S Xu, et al.
Antibiotics and Chemotherapy|January 1, 1996
Vaccination of mice and nonhuman primates using HIV-gene-containing DNAM A Liu, Y Yasutomi, M E Davies, et al.
Vaccine|August 7, 1999
Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope proteinX Liang, S Munshi, J Shendure, et al.
Vaccine|June 1, 1997
Anti-HIV env immunities elicited by nucleic acid vaccinesJ W Shiver, M E Davies, Y Yasutomi, et al.
Nature Medicine|June 1, 1995
Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virusJ J Donnelly, A Friedman, D Martinez, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|December 1, 1996
Humoral and cellular immunities elicited by HIV-1 vaccinationJ W Shiver, M E Davies, H C Perry, et al.
Methods in Enzymology|January 1, 1989
Prediction of bilayer spanning domains of hydrophobic and amphipathic membrane proteins: application to the cytochrome b and colicin familiesJ W Shiver, A A Peterson, W R Widger, et al.
Current Opinion in Biotechnology|October 1, 1994
Protein expression in vivo by injection of polynucleotidesD L Montgomery, J J Donnelly, J W Shiver, et al.
The Journal of Biological Chemistry|October 15, 1987
On the explanation of the acidic pH requirement for in vitro activity of colicin E1. Site-directed mutagenesis at Glu-468J W Shiver, W A Cramer, F S Cohen, et al.
Immunology Letters|October 12, 2001
Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeysD H Barouch, T M Fu, D C Montefiori, et al.
The Journal of Biological Chemistry|February 5, 1989
Decrease of anion selectivity caused by mutation of Thr501 and Gly502 to Glu in the hydrophobic domain of the colicin E1 channelK Shirabe, F S Cohen, S Xu, et al.
Antibiotics and Chemotherapy|January 1, 1996
Vaccination of mice and nonhuman primates using HIV-gene-containing DNAM A Liu, Y Yasutomi, M E Davies, et al.
Vaccine|August 7, 1999
Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope proteinX Liang, S Munshi, J Shendure, et al.
Vaccine|June 1, 1997
Anti-HIV env immunities elicited by nucleic acid vaccinesJ W Shiver, M E Davies, Y Yasutomi, et al.
Nature Medicine|June 1, 1995
Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virusJ J Donnelly, A Friedman, D Martinez, et al.
Pageof 3